Loading...

MLC

MLC

MOOLEC SCIENCE SA

(MLEC)

2025 6-K

Filing Reported

31 Dec '25

Moolec Filing Update

31 Dec '25

Share Consolidation

16 Dec '25

EGM Adjournment Notice

12 Dec '25

Filing Update

28 Nov '25

Nasdaq Compliance Appeal

20 Nov '25

Potential Dispute

21 Oct '25

Moolec Filing Report

11 Sep '25

Company Update

12 Aug '25

Board Restructuring

18 Jun '25

Filing Report

17 Jun '25

EGM Approval

16 Jun '25

Extraordinary Meeting Notice

4 Jun '25

Foreign Issuer Report

13 May '25

Stock Split Announcement

29 Apr '25

Shareholder Meeting Outcome

22 Apr '25

Filing Report

21 Apr '25

Business Combination Update

17 Apr '25

Financial Reporting

16 Apr '25

Board Resignations

9 Apr '25

Extraordinary Meeting Notice

7 Apr '25

Nasdaq Compliance Update

4 Apr '25

Nasdaq Delisting Notice

14 Mar '25

Financial Update

31 Jan '25

Annual Meetings Held

27 Dec '24

Office Relocation

13 Dec '24

Filing Report

16 Oct '24

Business Update

4 Oct '24

Filing Report

13 Sep '24

Moolec Filing Update

9 Aug '24

Foreign Filing Report

15 Jul '24

Foreign Issuer Report

28 Jun '24

Business Update

31 May '24

6-K Filing Summary

24 May '24

Filing Report

30 Apr '24

6-K Filing Update

23 Apr '24

Financial Report

18 Apr '24

Shareholder Meeting Summary

12 Mar '24

Annual Meeting Notice

26 Feb '24

Financial Report

22 Jan '24

External Links:

SEC

Moolec Science SA reported that on May 14, 2025, it executed a reverse stock split of 10-to-1 and relocated its jurisdiction from Luxembourg to the Cayman Islands on May 22, 2025. Additionally, on June 16, 2025, a business combination was ratified, involving Bioceres Group Limited and others, with significant debt restructuring concerns raised regarding Bioceres S.A.'s $36.4 million in defaulted debt.

AI Assistant

MOOLEC SCIENCE SA

2025

6 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.